# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-23-000018
Filing Date
2023-04-20
Accepted
2023-04-20 16:05:58
Documents
26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | lngd-20230420.htm iXBRL | DEF 14A | 1301707
6 | LIGAND LOGO | lngd-20230420_g1.jpg | GRAPHIC | 51754
7 |  | lngd-20230420_g10.jpg | GRAPHIC | 323549
8 |  | lngd-20230420_g11.jpg | GRAPHIC | 337180
9 |  | lngd-20230420_g12.jpg | GRAPHIC | 249158
10 |  | lngd-20230420_g2.jpg | GRAPHIC | 159220
11 |  | lngd-20230420_g3.jpg | GRAPHIC | 69063
12 |  | lngd-20230420_g4.jpg | GRAPHIC | 29101
13 |  | lngd-20230420_g5.jpg | GRAPHIC | 33733
14 |  | lngd-20230420_g6.jpg | GRAPHIC | 57322
15 |  | lngd-20230420_g7.jpg | GRAPHIC | 48407
16 |  | lngd-20230420_g8.jpg | GRAPHIC | 481529
17 |  | lngd-20230420_g9.jpg | GRAPHIC | 336544
| Complete submission text file | 0000886163-23-000018.txt |  | 7074816

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lngd-20230420.xsd | EX-101.SCH | 4386
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lngd-20230420_def.xml | EX-101.DEF | 6383
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lngd-20230420_lab.xml | EX-101.LAB | 9094
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lngd-20230420_pre.xml | EX-101.PRE | 5682
20 | EXTRACTED XBRL INSTANCE DOCUMENT | lngd-20230420_htm.xml | XML | 188336

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 23833152
SIC: 2834 Pharmaceutical Preparations